19th Annual International Ultmann Chicago Lymphoma Symposium

 

19th Annual International Ultmann Chicago Lymphoma Symposium
A

Hodgkin Lymphoma Updates: Relapse After Auto-HCT, Brentuximab Vedotin, and Checkpoint Inhibitors - The Next Frontier

By 19th Annual International Ultmann Chicago Lymphoma Symposium FEATURING Anna Sureda
By 19th Annual International Ultmann Chicago Lymphoma Symposium FEATURING Anna Sureda
31 views
July 11, 2022
0 Comments
Login to view comments. Click here to Login
Videos
15:36
19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of 1st Relapsed Classical Hodgkin Lymphoma

Feat. V. Kenkre
12:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Targeted Agents in Follicular Lymphoma: Small Molecules

Feat. T. Phillips
19:06
19th Annual International Ultmann Chicago Lymphoma Symposium

Primary CNS Lymphoma: Focus on Consolidation

Feat. T. Batchelor
20:01
19th Annual International Ultmann Chicago Lymphoma Symposium

CAR T-Cell Constructs in Lymphoma: Current and Future Options

Feat. T. Siddiqi
54:37
19th Annual International Ultmann Chicago Lymphoma Symposium

Toxicities Associated With Chronic Therapies for Lymphoma: Case Stud…

Feat. N. Soriano, K. Thorp
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium

CAR T-Cell Therapy and Emerging Bispecifics for the Treatment of Fol…

Feat. S. Ahmed
20:03
19th Annual International Ultmann Chicago Lymphoma Symposium

Biology of Follicular Lymphoma

Feat. R. Kridel
25:29
19th Annual International Ultmann Chicago Lymphoma Symposium

Mantle Cell Lymphoma: Case-Based Approach to Management

Feat. R. Karmali
20:13
19th Annual International Ultmann Chicago Lymphoma Symposium

Bispecific Antibodies in Lymphomas

Feat. R. Bannerji
20:16
19th Annual International Ultmann Chicago Lymphoma Symposium

How to Sequence Non-CAR T-Cell Therapy for Relapsed DLBCL

Feat. D. Landsburg
19:22
19th Annual International Ultmann Chicago Lymphoma Symposium

Prevention of CNS Progression in DLBCL

Feat. C. Portell
19:28
19th Annual International Ultmann Chicago Lymphoma Symposium

Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Tre…

Feat. C. Steidl
19:37
19th Annual International Ultmann Chicago Lymphoma Symposium

Hodgkin Lymphoma Updates: Relapse After Auto-HCT, Brentuximab Vedoti…

Feat. A. Sureda
42:23
19th Annual International Ultmann Chicago Lymphoma Symposium

COVID-19 in Patients With Lymphoma: Treatment Approaches, Vaccinatio…

Feat. N. Pettit
24:15
19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of Relapsed CNS Lymphomas

Feat. A. Ferreri
24:14
19th Annual International Ultmann Chicago Lymphoma Symposium

Prognostication and Treatment of Burkitt Lymphoma in the Modern Era

Feat. A. Olszewski
48:49
19th Annual International Ultmann Chicago Lymphoma Symposium

Recent Advances in the Frontline Treatment of DLBCL: Is There a New …

Feat. L. Sehn
38:14
19th Annual International Ultmann Chicago Lymphoma Symposium

Cellular Therapy in Lymphoma: Where Are We Now?

Feat. P. Riedell
17:54
19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: Auto-HCT Remains the Preferred Standard of Care for 1L Thera…

Feat. T. Fenske
14:38
19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: We Should Stop Doing Autotransplants for Patients With MCL i…

Feat. P. Stiff
19:52
19th Annual International Ultmann Chicago Lymphoma Symposium

CLL: Present and Future

Feat. N. Lamanna
19:38
19th Annual International Ultmann Chicago Lymphoma Symposium

T-Cell Lymphomas: Impact of Classification on Treatment

Feat. N. Mehta-Shah
20:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Post-Acute Outcomes After HL: An Epidemiologic Perspective

Feat. L. Morton
28:22
19th Annual International Ultmann Chicago Lymphoma Symposium

Follicular Lymphoma Management in the COVID-19 Era

Feat. L. Gordon
41:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

Feat. K. Cohen
17:53
19th Annual International Ultmann Chicago Lymphoma Symposium

Sequencing of Therapies in R/R MCL

Feat. K. Maddocks
22:11
19th Annual International Ultmann Chicago Lymphoma Symposium

High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differe…

Feat. D. Scott